Subscribe to Seeking Alpha feed
https://seekingalpha.com
URL: https://seekingalpha.com
Updated: 40 min 13 sec ago

Ferrovial SE 2025 Q4 - Results - Earnings Call Presentation

Thu, 02/26/2026 - 22:00

Warby Parker outlines launch of AI glasses and targets 10%–12% revenue growth in 2026 while expanding omnichannel footprint

Thu, 02/26/2026 - 21:58

PureCycle outlines 2026 commercial ramp with 170+ project pipeline and expanded compounding capabilities

Thu, 02/26/2026 - 21:48

Syndax signals expanding Revuforj market share and targets $10B addressable opportunity while ramping Niktimvo

Thu, 02/26/2026 - 21:48

Figure: A Buy As Loan Types Increase

Thu, 02/26/2026 - 21:40

Crinetics outlines $600M–$650M 2026 operating expense plan as PALSONIFY launch accelerates

Thu, 02/26/2026 - 21:38

AMD Is A No-Brainer Once More

Thu, 02/26/2026 - 21:32

Tenaga Nasional Berhad 2025 Q4 - Results - Earnings Call Presentation

Thu, 02/26/2026 - 21:32

SSE: Still Looks Overpriced, With Heavy Capex Plans

Thu, 02/26/2026 - 21:29

Cable One targets Q1 2026 mobile launch and $480M MBI acquisition while advancing multi-gig upgrades

Thu, 02/26/2026 - 21:28

PACS Group outlines 8% revenue growth target for 2026 as integration drives record year

Thu, 02/26/2026 - 21:28

Silver Down 3% - Large Range Formation Building?

Thu, 02/26/2026 - 21:25

The Honest Company: Strong Cash Position As Transformation Gains Traction

Thu, 02/26/2026 - 21:20

Seer outlines $16M–$18M 2026 revenue target as product innovation accelerates and new buyback approved

Thu, 02/26/2026 - 21:18

Autodesk outlines $8.1B–$8.17B FY27 revenue target amid go-to-market restructuring and AI expansion

Thu, 02/26/2026 - 21:08

AvePoint targets 27% ARR growth for 2026 as AI-driven demand accelerates

Thu, 02/26/2026 - 21:08

Coreweave targets $12b–$13b 2026 revenue with accelerated $30b–$35b capex amid surging ai demand

Thu, 02/26/2026 - 21:08

CoreWeave, Inc. 2025 Q4 - Results - Earnings Call Presentation

Thu, 02/26/2026 - 21:01

Invesco Small Cap Value Fund Q4 2025 Commentary

Thu, 02/26/2026 - 21:00

Definium Therapeutics targets three pivotal Phase III readouts in 2026 as enrollment advances and cash runway extends into 2028

Thu, 02/26/2026 - 20:58

Pages